Scottsdale, Arizona - January 14, 2010 - MedApps, Inc., a leading mHealth (mobile / remote health monitoring) company, announced today that it will partner with Meridian Health, a leading comprehensive healthcare provider in New Jersey, to initiate a chronic disease management pilot focused on patients discharged from acute care settings with Congestive Heart Failure (CHF). The focus of the program is to monitor the participants on a daily, near real-time basis, to improve patient outcomes and decrease re-admissions to the hospitals within 30 days.
Wireless continues wireline cannibalization: According to report from the CDC, preliminary results from the January-June 2009 National Health Interview Survey (NHIS) indicate that the number of American homes that only use mobile phones (no landlines) continues to increase. Some 22.7 percent of U.S. homes only used mobile phones during the first six months of 2009. That marks an increase of 2.5 percent over the same period in 2008. What's more, some 14.7 percent of homes with landlines receive all or nearly all calls on their mobiles.
The FDA recently approved MediSens Wireless' wireless body monitoring system, which assesses muscle and neuromotor functions in the upper extremities, for its first phase of clinical trials. MediSens' Clinical Movement Assessment System (CMAS) could be used by health care professionals working in physical medicine and rehabilitation, neurology, orthopedics and physical and occupational therapy.
After three months of rumors, details surrounding Epic Systems' partnership with Apple for a mobile phone-based electronic health record (EHR) application have come to light: Just a few days ago, Epic System's iPhone application, called Haiku, became available on Apple's AppStore.
Anthem Blue Cross, the trade name for Blue Cross of California, announced plans last week to work with wireless health company Ideal Life on a pilot program for congestive heart failure (CHF) patients called CARE (Congestive Heart Failure Ambulatory Remote monitoring and Engagement). Ideal Life is providing its wireless body weight scales for in-home u
Anthem Blue Cross announced today that it has contracted with IDEAL LIFE® to provide wireless body weight scales for in-home use with Congestive heart Failure (CHF) patients. This initiative is the foundation of a new pilot program known as C.A.R.E. (Congestive Heart Failure Ambulatory Remote monitoring and Engagement).
Last week we reported on Mayo Clinic's new mobile-focused startup: mRemedy, which is creating smartphone applications based on Mayo's medical research. mRemedy is a joint collaboration with application developer DoApps. The venture's first application was a meditation application that teaches users breathing exercises and other methods for reducing stress.
Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical's sensing technology for organ transplantation.
REDWOOD CITY, Calif. - Proteus Biomedical Inc., a pioneer in intelligent medicine, entered into an exclusive worldwide license and collaboration agreement with Novartis to develop and commercialize pharmaceutical products that incorporate Proteus’ novel sensor-based technologies in the field of organ transplantation. Novartis also receives certain option rights in cardiovascular and oncology product applications, as well as rights to use Proteus technologies in its clinical development of pharmaceutical products.